PLoS ONE (Jan 2013)

HDL-apoA-I exchange: rapid detection and association with atherosclerosis.

  • Mark S Borja,
  • Lei Zhao,
  • Bradley Hammerson,
  • Chongren Tang,
  • Richard Yang,
  • Nancy Carson,
  • Gayani Fernando,
  • Xiaoqin Liu,
  • Madhu S Budamagunta,
  • Jacques Genest,
  • Gregory C Shearer,
  • Franck Duclos,
  • Michael N Oda

DOI
https://doi.org/10.1371/journal.pone.0071541
Journal volume & issue
Vol. 8, no. 8
p. e71541

Abstract

Read online

High density lipoprotein (HDL) cholesterol levels are associated with decreased risk of cardiovascular disease, but not all HDL are functionally equivalent. A primary determinant of HDL functional status is the conformational adaptability of its main protein component, apoA-I, an exchangeable apolipoprotein. Chemical modification of apoA-I, as may occur under conditions of inflammation or diabetes, can severely impair HDL function and is associated with the presence of cardiovascular disease. Chemical modification of apoA-I also impairs its ability to exchange on and off HDL, a critical process in reverse cholesterol transport. In this study, we developed a method using electron paramagnetic resonance spectroscopy (EPR) to quantify HDL-apoA-I exchange. Using this approach, we measured the degree of HDL-apoA-I exchange for HDL isolated from rabbits fed a high fat, high cholesterol diet, as well as human subjects with acute coronary syndrome and metabolic syndrome. We observed that HDL-apoA-I exchange was markedly reduced when atherosclerosis was present, or when the subject carries at least one risk factor of cardiovascular disease. These results show that HDL-apoA-I exchange is a clinically relevant measure of HDL function pertinent to cardiovascular disease.